Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 02 - 25 save search
First Industrial Realty Trust Announces Appointment of Marcus L. Smith to Its Board of Directors
Published: 2021-02-25 (Crawled : 22:08) - prnewswire.com
FR | $46.07 -5.21% 0.0% 2.4M
|
Finance
|
| O: 0.63%
H: 0.0%
C: -1.59%
arcus trial
Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
REGN | $893.99 -0.8% -0.84% 450K
|
Health Technology
|
| O: 0.37%
H: 1.02%
C: -1.55%
covid phase 3 trial casirivimab
BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related AgitationTopline results are expected in Q1 2022
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
BTAI | $2.55 -1.54% -1.17% 230K
|
Health Technology
|
| O: 0.84%
H: 5.05%
C: -4.02%
treatment phase 2 results trial
EH216 Completed Its First Trial Flights Over the Sea of Southern China to Explore New Scenarios for Coastal Urban Air Mobility
Published: 2021-02-25 (Crawled : 16:00) - globenewswire.com
EH | $18.29 5.66% 5.46% 1.5M
|
Technology Services
|
| O: -2.92%
H: 4.74%
C: -12.89%
china trial
Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD™ Phase 3 Trial
Published: 2021-02-25 (Crawled : 15:00) - globenewswire.com
ADIL | $2.17 -6.47% -6.91% 150K
|
Health Technology
|
| O: -1.6%
H: 6.82%
C: -10.71%
phase 3 trial enroll
Kronos Bio Announces First Patient Dosed in Phase 1/2 Clinical Trial of KB-0742, an Oral CDK9 Inhibitor Targeting MYC-amplified Cancers
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
KRON | $1.03 -0.96% -2.97% 210K
|
Health Technology
|
| O: -0.79%
H: 1.86%
C: 0.52%
phase 1 cancer trial phase 3 phase 2
DTRA Awards Leidos Project to Conduct Clinical Trials for COVID-19 Therapeutics
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
LDOS | $123.76 -0.48% -0.61% 870K
|
Technology Services
|
| O: -0.42%
H: 0.28%
C: -0.97%
covid trial covid-19 awards
CNS Pharmaceuticals Berubicin Trial is On Schedule to Commence in March 2021
Published: 2021-02-25 (Crawled : 15:00) - biospace.com/
CNSP | $0.204 -0.2% -3.49% 130K
|
Health Technology
|
| O: 1.36%
H: 1.0%
C: -3.68%
berubicin trial
Altimmune Commences Enrollment in Phase 1 Clinical Trial of AdCOVID™ -- a Needle-Free, Single-Dose Intranasal COVID-19 Vaccine Candidate
Published: 2021-02-25 (Crawled : 12:05) - globenewswire.com
ALT | $6.89 -2.13% -2.03% 2.7M
|
Commercial Services
|
| O: -3.93%
H: 4.68%
C: -8.56%
covid adcovid phase 1 vaccine trial phase 3 phase 2 enroll
Chimerix Reports Promising Topline Results from First Cohort of a Randomized COVID-19 Trial with DSTAT
Published: 2021-02-25 (Crawled : 12:03) - globenewswire.com
CMRX | $0.9323 3.13% 3.83% 360K
|
Health Technology
|
| O: 0.69%
H: 6.44%
C: 4.1%
covid results trial topline covid-19
BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related Agitation
Published: 2021-02-25 (Crawled : 12:03) - globenewswire.com
BTAI | $2.55 -1.54% -1.17% 230K
|
Health Technology
|
| O: 0.84%
H: 5.05%
C: -4.02%
treatment phase 2 trial
SpringWorks Therapeutics Reports Interim Data from Phase 2b ReNeu Trial of Mirdametinib for Patients with NF1-PN and Provides Trial Update
Published: 2021-02-25 (Crawled : 12:00) - globenewswire.com
SWTX | News | $42.47 -3.72% -3.84% 810K
|
Health Technology
|
| O: -1.43%
H: 4.26%
C: -3.52%
phase 2 phase 2b trial
Gainers vs Losers
| 59% | 41% |
Top 10 Gainers
AGBA | News | $1.03 157.5% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.5 45.65% 470K
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.82 42.08% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.